• 207, Ikorodu Road, Ilupeju, Lagos, Nigeria
  • [email protected]
Logo
  • Home
  • About Us
    • Board of Directors
    • Executive Team
    • CEO’s Message
    • Quality Statement
  • Our Products
    • Codix Specialties Products
    • Consumer Health Products
    • Aftersales Support
  • Responsibilities
    • Codix Charity Foundation
  • Media
    • Gallery
    • News
    • Blog
  • Careers
Logo

SD Biosensor’s Standard Q Covid-19 Ag Home Test Receives US FDA Emergency Use Authorization

Codix Pharma > Blog > Publications > SD Biosensor’s Standard Q Covid-19 Ag Home Test Receives US FDA Emergency Use Authorization
  • CpharmaCpharma
  • May 3, 2024
  • Publications
  • No Comments

SD Biosensor’s Standard Q Covid-19 Ag Home Test Receives US FDA Emergency Use Authorization

Read More

Standard M10 Point-of-care MDx System Receives MLSCN Approval

Prev Post

SD Biosensor’s Standard QCovid-19 Ag Home Test Receives US FDAEmergency Use Authorization

Next Post

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

  • Biosensors Curriculum at OOU Records Milestone with Two Cohorts Graduated under Codix Partnership
  • Codix Bio announced as the First Partner Factory Under WHO H-TAP Program, Strengthening Nigeria’s Healthcare Manufacturing
  • Are you addicted to sugar?
  • Can I Gain Weight with Multivitamin Tablets?
  • Is multivitamin good for a sickle cell patient?
Codix pharma logo
  • 207, Ikorodu Road, Ilupeju, Lagos, Nigeria.
  • +234 808 526 4255
  • Mon – Fri: 8 am – 5 pm

Quicklinks

  • FAQ
  • Publications
  • Our Blog
  • Privacy Policy

Resources

  • Certifications
  • Sitemaps

Our Newsletter

Sign up to our weekly newsletter to get the latest updates.

Copyright © 2025 Codix Pharma | Powered by Codix Pharma